Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market

August 17, 2021 at 11:58 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - On Sun. Aug. 22^nd at 5pm EST broadcast on FOX Business News — BTV-Business Television explores the burgeoning sector that has captured the attention of investors - psychedelics.

Cannot view this video? Visit:
https://b-tv.com/btv-examines-the-rapidly-expanding-psychedelics-market-ep-362/

Discover Companies to Invest In - Click company name to watch their TV feature:

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) — Researching and developing DMT, one of the most powerful psychedelics in existence, to address substance use disorders related to nicotine, alcohol, and opioids. Elemer Piros, Analyst at Roth Capital Partners, weighs in.

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) — BTV reports on their pre-clinical studies underway with a proprietary extract from the Amanita Muscaria mushroom.

Small Pharma Inc. (TSXV: DMT) — BTV learns about DMT, a psychedelic that is the subject of a Small Pharma clinical trial dealing with depression — the world's first.

Numinus Wellness Inc. (TSXV: NUMI) — BTV checks in with a company at the forefront of a new and innovative mental health treatment focused on psychedelic assisted psychotherapy.

Mydecine Innovations Group (NEO: MYCO) (OTC Pink: MYCOF) — BTV discovers how this company is developing psilocybin-based psychedelic treatments to better address the affects of addiction and post traumatic stress disorder.

On air for over 20 years, BTV - Business Television, a half-hour investment TV show, features analysts and emerging publicly traded companies at their location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV provides viewers with investment opportunities.

Suggest a Company to Feature!
Contact: (604) 664-7401 x3 info@b-tv.com

Corporate Logo